The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels
- 1 October 2002
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 452 (2) , 223-228
- https://doi.org/10.1016/s0014-2999(02)02307-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene‐related peptide induced dilation of dural meningeal vesselsBritish Journal of Pharmacology, 2002
- Migraine — Current Understanding and TreatmentNew England Journal of Medicine, 2002
- The effect of adrenergic compounds on neurogenic dural vasodilatationEuropean Journal of Pharmacology, 2001
- Indomethacin increases the effect of isosorbide dinitrate on cerebral hemodynamic in migraine patients: pathogenetic and therapeutic implications.Cephalalgia, 1998
- Flunarizine, an anti-migraine agent, impairs nitroxidergic nerve function in cerebral arteriesEuropean Journal of Pharmacology, 1997
- Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascadeJournal of Neuroscience, 1995
- Nitroglycerin-Induced Headache is Not Dependent on Histamine Release: Support For a Direct Nociceptive Action of Nitric OxideCephalalgia, 1994
- K+-stimulated 45Ca2+ flux into rat neocortical mini-slices is blocked by ω-Aga-IVA and the dual channel blockers lidoflazine and flunarizineNeuroscience Letters, 1993
- Noxious stimulus-induced increase in spinal prostaglandin E2 is noradrenergic terminal-dependentNeuroscience Letters, 1990
- Inhibition of Prostaglandin Synthesis in Rat BrainActa Pharmacologica et Toxicologica, 1978